Propanc Biopharma Inc
NASDAQ:PPCB
Propanc Biopharma Inc
NASDAQ:PPCB
Price:
0.175
USD
-58.72%
Market Closed
Market Cap:
$2.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Propanc Biopharma Inc
NASDAQ:PPCB
|
AU |
|
L
|
Lam Dong Investment and Hydraulic Construction JSC
VN:LHC
|
VN |
|
Digital Brands Group Inc
OTC:DBGI
|
US |
|
K
|
KBI Dongkook Ind Co Ltd
KRX:001620
|
KR |
|
Exeo Entertainment Inc
OTC:EXEO
|
US |
|
S
|
Simmtech Holdings Co Ltd
KOSDAQ:036710
|
KR |
|
Dongwon F & B Co Ltd
KRX:049770
|
KR |
|
G
|
Guangzhou Rural Commercial Bank Co Ltd
HKEX:1551
|
CN |
|
K
|
Kosy JSC
VN:KOS
|
VN |
Balance Sheet
Balance Sheet Decomposition
Propanc Biopharma Inc
Propanc Biopharma Inc
Balance Sheet Decomposition is not available for
Propanc Biopharma Inc
Propanc Biopharma Inc
Balance Sheet
Propanc Biopharma Inc
Propanc Biopharma Inc
Currency: USD
| Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
-87%
|
0
+524%
|
0
-26%
|
0
+20%
|
|
| Liabilities | ||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
1
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
2
|
1
|
1
|
1
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
4
|
3
|
3
|
3
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
4
N/A
|
3
-18%
|
3
+1%
|
3
+2%
|
4
+21%
|
|
| Equity | ||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
56
|
58
|
62
|
65
|
67
|
|
| Additional Paid In Capital |
51
|
54
|
57
|
60
|
61
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
1
|
1
|
1
|
1
|
1
|
|
| Total Equity |
4
N/A
|
3
+16%
|
3
+1%
|
3
-3%
|
4
-21%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
-87%
|
0
+524%
|
0
-26%
|
0
+20%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
|
| Preferred Shares Outstanding |
1
|
1
|
1
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
